As the COVID-19 pandemic has evolved during the past years, interactions between human
immune systems, rapidly mutating and selected SARS-CoV-2 viral variants, and effective …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of vaccinated
individuals is increasingly common but rarely results in severe disease, likely due to the …

In response to the emergence of SARS-CoV-2 variants of concern, the global scientific
community, through unprecedented effort, has sequenced and shared over 11 million …

Infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and
vaccinations targeting the spike protein (S) offer protective immunity against coronavirus …

Abstract SARS-CoV-2 Omicron (B. 1.1. 529) BA. 4 and BA. 5 sub-lineages, first detected in
South Africa, have changes relative to Omicron BA. 1 including substitutions in the spike …

SARS-CoV-2 clearance requires adaptive immunity but the contribution of neutralizing
antibodies and T cells in different immune states is unclear. Here we ask which adaptive …

There has been substantial research on adult COVID-19 and how to treat it. But how do
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections afflict children …

Several studies have shown that SARS-CoV-2 BA. 1 omicron is an immune escape variant.
Meanwhile, however, omicron BA. 2 and BA. 5 became dominant in many countries and …

Background Data on response and safety of repeated vaccinations and hybrid immunity in
patients with immune-mediated inflammatory diseases on immunosuppressive therapy is …

Infection with SARS-CoV-2 in humans has caused a pandemic of unprecedented
dimensions. SARS-CoV-2 is primarily transmitted through respiratory droplets and targets …